Ingevity Corporation (NYSE:NGVT) Given Consensus Recommendation of “Hold” by Analysts

Ingevity Corporation (NYSE:NGVT) has received a consensus recommendation of “Hold” from the five research firms that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $80.00.

A number of equities analysts have recently commented on the stock. Wall Street Zen lowered shares of Ingevity from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 1st. Weiss Ratings raised shares of Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a report on Friday, July 31st.

Ingevity Price Performance

Ingevity stock opened at $71.33 on Thursday. The stock has a market cap of $2.45 billion, a price-to-earnings ratio of 48.53 and a beta of 1.16. The company has a quick ratio of 1.15, a current ratio of 1.61 and a debt-to-equity ratio of 22.52. The business has a 50-day simple moving average of $73.91 and a 200 day simple moving average of $71.82. Ingevity has a 52 week low of $45.85 and a 52 week high of $79.29.

Ingevity (NYSE:NGVT) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $1.74 EPS for the quarter, topping the consensus estimate of $1.33 by $0.41. The company had revenue of $314.10 million during the quarter, compared to analyst estimates of $312.20 million. Ingevity had a return on equity of 284.70% and a net margin of 4.65%.Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. On average, research analysts forecast that Ingevity will post 5.4 earnings per share for the current fiscal year.

Insider Buying and Selling at Ingevity

In other news, CEO David H. Li sold 5,000 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $75.83, for a total transaction of $379,150.00. Following the transaction, the chief executive officer directly owned 120,636 shares in the company, valued at approximately $9,147,827.88. This represents a 3.98% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Terrance M. Dyer sold 496 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $68.49, for a total value of $33,971.04. Following the transaction, the senior vice president owned 7,202 shares in the company, valued at $493,264.98. This trade represents a 6.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 18,297 shares of company stock worth $1,381,452 over the last 90 days. Corporate insiders own 0.88% of the company’s stock.

Institutional Trading of Ingevity

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Global Retirement Partners LLC bought a new position in Ingevity during the fourth quarter valued at approximately $27,000. Meeder Asset Management Inc. bought a new stake in shares of Ingevity in the 4th quarter worth approximately $33,000. Geneos Wealth Management Inc. lifted its holdings in shares of Ingevity by 85.8% in the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after acquiring an additional 387 shares during the last quarter. Frazier Financial Advisors LLC purchased a new stake in shares of Ingevity in the 2nd quarter valued at $37,000. Finally, Headlands Technologies LLC purchased a new stake in shares of Ingevity in the 2nd quarter valued at $46,000. Hedge funds and other institutional investors own 91.59% of the company’s stock.

About Ingevity

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.